| HOME >> BIOLOGY >> TECHNOLOGY |
Figure 48: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 88
Figure 49: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 90
Figure 50: Retroviruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 92
Figure 51: Retroviruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 93
Figure 52: Hepatitis Viruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 94
Figure 53: Hepatitis Viruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 95
Figure 54: Other Virology, China, Revenue ($m), USD Constant, Historic, 2004-2011 96
Figure 55: Other Virology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 97
Figure 56: Bacteriology, China, Revenue ($m), USD Constant, Historic, 2004-2011 98
Figure 57: Bacteriology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 99
Figure 58: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 100
Figure 59: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 102
Figure 60: Infectious Immunology, China, Company Share (%), 2011 105
Figure 61: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 107
Figure 62: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 109
Figure 63: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 111
Figure 64: Retroviruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 113
Figure 65: Retroviruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 114
Figure 66: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 115
Figure 67:
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |